Shake Shack Financials - Benzinga

Shake Shack Inc

SHAKNYSE

Trade with Public

Trade with Public

$75.82

1.972.67%

At close: Aug 21, 5:00 PM EST

$75.81

-0.009-0.01%

After Hours: Aug 21, 6:51 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Shake Shack Financials

Shake Shack (SHAK) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Shake Shack Tops Q2 Expectations as Sales Rise 17% and Labor Costs Ease

Shake Shack earnings topped estimates as revenue climbed 17.2%, though restaurant margins narrowed and costs rose.

Akanksha Bakshi

PRO
Shake Shack Affirms FY2026 Sales Guidance of $1.600B-$1.700B vs $1.650B Est

Shake Shack (NYSE:SHAK) affirms FY2026 sales outlook from $1.600 billion-$1.700 billion to $1.600 billion-$1.700 billion vs $1.650 billion estimate.

Benzinga Newsdesk

PRO
Shake Shack Q2 Adj. EPS $0.43 Beats $0.30 Estimate, Sales $417.618M Beat $417.185M Estimate

Shake Shack (NYSE:SHAK) reported quarterly earnings of $0.43 per share which beat the analyst consensus estimate of $0.30 by 38.71 percent. This is a 2.27 percent decrease over earnings of $0.44 per share from the same

Benzinga Newsdesk

Shake Shack Trims Guidance Amid Macro, Competition Heat

Shake Shack cut EBITDA and net income outlooks as market uncertainty and competitive pressures weighed on expectations.

Lekha Gupta

PRO
Shake Shack Lowers Q2 Guidance, Cuts Revenue Guidance From $424M-$428M To $415M-$420M, Same-Shack Sales From 3%-5% To 2.5%-3%, FY EBITDA From $230M-$245M To $225M-$235M, And Net Income From $50M-$60M To $45M-$55M

Management Updates GuidanceShake Shack Inc. ("Shake Shack" or the "Company") (NYSE:SHAK) provided a business update for the fiscal second quarter ending July 1, 2026 and fiscal year ending December 30, 2026, ahead of

Benzinga Newsdesk

PRO
Shake Shack Lowers Q2 Preliminary Sales Guidance from $424.000M-$428.000M to $415.000M-$420.000M vs $371.898M Est

Shake Shack (NYSE:SHAK) lowers Preliminary Q2 sales outlook from $424.000 million-$428.000 million to $415.000 million-$420.000 million vs $371.898 million estimate.

Benzinga Newsdesk